NASDAQ: EPRXEupraxia Pharmaceuticals Inc Stock Ownership - Who owns Eupraxia Pharmaceuticals?
Insider buying vs selling
Have Eupraxia Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when EPRX insiders and whales buy or sell their stock.
EPRX Shareholders
What type of owners hold Eupraxia Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Scotia Capital Inc | 3.59% | 1,291,989 | $6.87M | Institution |
| Royal Bank Of Canada | 1.19% | 428,584 | $2.28M | Institution |
| Goldman Sachs Group Inc | 0.11% | 39,800 | $211.54k | Institution |
| Ubs Group Ag | 0.10% | 37,499 | $199.31k | Institution |
| Bank Of Montreal | 0.10% | 37,250 | $197.98k | Institution |
| Ingalls Snyder LLC | 0.10% | 37,200 | $197.72k | Institution |
| Jpmorgan Chase Co | 0.05% | 18,717 | $99.48k | Institution |
| Citadel Advisors LLC | 0.05% | 18,236 | $96.92k | Institution |
| Cibc World Market Inc | 0.04% | 15,000 | $79.73k | Institution |
| Bank Of America Corp | 0.03% | 12,559 | $66.75k | Institution |
EPRX vs Biotech Stocks
Eupraxia Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.